Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

AI in Genomics and Reporting for Clinical Practice

Genomic medicine: cracking genomes to cure 'incurable' diseases

Frontiers Personalized medicine in a community health system: the NorthShore experience

5 Process for the Return of Genetic Results (Session 4) Considerations for Returning Individual Genomic Results from Population-Based Surveys: Focus on the National Health and Nutrition Examination Survey: Proceedings of a

Past Events

Frontiers Next-Generation Sequencing in Newborn Screening: A Review of Current State

Sue Ann Molero on LinkedIn: #ngs #spatial #transcriptomics

Labroots Genetics Week Virtual Event Series 2022

The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world - The Lancet

Next generation sequencing (NGS) in the MDS study